Here's the live share price of Everest Organics along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Everest Organics | 15.01 | -4.23 | -36.42 | -26.33 | -14.10 | 37.92 | 2.12 |
| Sun Pharmaceutical Industries | 0.80 | -6.23 | -0.33 | -1.22 | -4.36 | 18.40 | 21.11 |
| Divi's Laboratories | 2.42 | 2.00 | 2.06 | -5.08 | 6.44 | 24.22 | 10.50 |
| Torrent Pharmaceuticals | 0.67 | -2.49 | 2.30 | 17.21 | 28.62 | 37.94 | 26.39 |
| Lupin | -0.25 | 1.05 | 6.82 | 19.65 | 15.82 | 49.34 | 17.00 |
| Dr. Reddy's Laboratories | -0.48 | -5.27 | 5.11 | -4.39 | 4.16 | 7.66 | 4.28 |
| Cipla | -0.09 | -3.13 | -11.69 | -25.06 | -18.72 | 9.94 | 5.35 |
| Zydus Lifesciences | 2.14 | 4.03 | 6.12 | -6.70 | 10.62 | 21.93 | 12.14 |
| Mankind Pharma | 2.80 | 1.65 | 0.90 | -12.91 | -17.28 | 14.49 | 8.46 |
| Aurobindo Pharma | 1.08 | 7.53 | 16.91 | 24.05 | 13.66 | 33.21 | 7.16 |
| Alkem Laboratories | 3.58 | 5.35 | -1.86 | 1.43 | 12.58 | 18.71 | 15.46 |
| Glenmark Pharmaceuticals | 3.09 | 1.98 | 12.01 | 20.34 | 62.87 | 64.05 | 30.95 |
| Laurus Labs | 2.89 | 14.92 | 6.32 | 22.69 | 76.44 | 54.01 | 20.71 |
| Biocon | 2.78 | -6.28 | -4.71 | -1.62 | 7.94 | 15.57 | -2.49 |
| Abbott India | -0.66 | -2.66 | -7.83 | -14.42 | -17.15 | 4.36 | 11.73 |
| GlaxoSmithKline Pharmaceuticals | 1.62 | -0.12 | 4.40 | -11.42 | -13.62 | 25.20 | 11.29 |
| Anthem Biosciences | -2.83 | 11.65 | 17.67 | -0.47 | -0.91 | -0.30 | -0.18 |
| Ipca Laboratories | 0.81 | -4.81 | -1.36 | 15.50 | 3.11 | 20.95 | 6.20 |
| Ajanta Pharma | -0.80 | -8.98 | 3.47 | 14.20 | 3.85 | 28.92 | 19.24 |
| J B Chemicals & Pharmaceuticals | -0.54 | -5.80 | 3.35 | 17.94 | 20.65 | 23.61 | 25.83 |
Over the last one year, Everest Organics has declined 14.10% compared to peers like Sun Pharmaceutical Industries (-4.36%), Divi's Laboratories (6.44%), Torrent Pharmaceuticals (28.62%). From a 5 year perspective, Everest Organics has underperformed peers relative to Sun Pharmaceutical Industries (21.11%) and Divi's Laboratories (10.50%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 248.82 | 251.8 |
| 10 | 240.72 | 246.79 |
| 20 | 246.97 | 254.89 |
| 50 | 311.23 | 301.09 |
| 100 | 382.44 | 343 |
| 200 | 380.31 | 354.55 |
In the latest quarter, Everest Organics saw a drop in promoter holding to 59.58%, while DII stake unchanged at 0.02%, FII holding unchanged at 0.00%, and public shareholding moved up to 40.40% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Apr 10, 2026, 08:37 PM IST IST | Everest Organics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 06, 2026, 05:49 AM IST IST | Everest Organics - Disclosure Of Reasons For Delay In Submission Of Financial Results For The Quarter Ended December 31, 2025 |
| Feb 15, 2026, 06:54 AM IST IST | Everest Organics - Unaudited Financial Results For The Quarter Ended And Nine Months Ended December 31, 2025. |
| Feb 15, 2026, 06:39 AM IST IST | Everest Organics - Board Meeting Outcome for Outcome Of Board Meeting Dated February 14, 2026 - Unaudited Financial Results O |
| Feb 15, 2026, 06:38 AM IST IST | Everest Organics - Board Meeting Outcome for Outcome Of Board Meeting Dated February 14, 2026 - Unaudited Financial Results O |
Everest Organics Ltd. is a Public Limited Listed company incorporated on 19/02/1993 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1993PLC015426 and registration number is 015426. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 159.48 Cr. and Equity Capital is Rs. 9.71 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Everest Organics is ₹275.00 as on Apr 20, 2026.
The Everest Organics is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Everest Organics is ₹267.04 Cr as on Apr 20, 2026.
Today’s highest and lowest price of Everest Organics are ₹280.00 and ₹261.00.
The 52-week high/low is the highest and lowest price at which Everest Organics stock has traded in the past 52-week or nearly a year. The 52-week high of Everest Organics is ₹536.40 and 52-week low of Everest Organics is ₹197.00 as on Apr 20, 2026.
The Everest Organics has shown returns of 2.71% over the past day, -4.23% for the past month, -36.42% over 3 months, -14.1% over 1 year, 37.92% across 3 years, and 2.12% over 5 years.
P/E ratio of and PB ratio of Everest Organics are 45.80 and 3.66 on Apr 20, 2026. While the company gives a dividend yield of 0.00 per annum.